Clinical Trial Update: Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients [Phase 1]

View source ↗

Summary

This Phase 1 trial update assesses the effect of SGLT-2 inhibitors on body mass index after three months in patients with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• SGLT-2 inhibitors

Snippet

Sponsor: Ariba Shafiq | Conditions: Diabete Mellitus | Phase 1 | Status: COMPLETED